Navigation Links
China Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2013
Date:8/22/2012

HONG KONG, Aug. 22, 2012 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its preliminary unaudited financial results for the first quarter of fiscal year 2013, which ended June 30, 2012.

First Quarter of Fiscal 2013 Highlights

  • Revenues for the first quarter of fiscal 2013 increased by 31.9% to RMB115.3 million ($18.2 million) from RMB87.5 million in the prior year period.
  • New subscriber sign-ups and accumulated subscriber base were 16,460 and 256,214, respectively.
  • Gross profit increased by 34.5% to RMB90.9 million ($14.3 million) from RMB67.6 million in the prior year period.
  • Operating income jumped by 44.4% to RMB44.4 million ($7.0 million) from RMB30.8 million in the prior year period. Operating margin expanded by 3.3 percentage points to 38.5%, as core operations benefited from economies of scale.
  • Interest expense increased to RMB10.2 million ($1.6 million) from RMB0.5 million as a result of the convertible note issued to KKR China Healthcare Investment Limited ("KKR") in April 2012.
  • In the absence of the dividend income from our investment in Shandong Cord Blood Bank and discrete tax benefit of our Guangdong subsidiary, both of which took place in the first quarter of fiscal 2012, together with the first-time interest expense in relation to the convertible note that was issued in April 2012, net income attributable to shareholders decreased by 22.3% to RMB31.1 million ($4.9 million) from RMB40.0 million in the prior year period.
  • Operating cash flow for the quarter amounted to RMB136.9 million ($21.5 million).
  • "I'm pleased to announce that new subscriber numbers have, once again, set a new record
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related biology technology :

    1. China Cord Blood Corporation to Report First Quarter of Fiscal 2013 Financial Results
    2. China Cord Blood Corporation and Cordlife Group Limited Foster Closer Alliance Across Asia
    3. China Biologic Reports Financial Results for the Second Quarter and First Half of 2012
    4. China Cord Blood Corporation Files its Annual Report on Form 20-F
    5. In Vitro Diagnostics (IVD) - Emerging Countries (Brazil, Russia, India, China) Opportunity Assessment, Competitive Landscape and Market Forecasts to 2018
    6. Pressure BioSciences, Inc. Continues Global Sales Reach Expansion with Distribution Agreements for China, Vietnam, Laos, Cambodia, Australia, and New Zealand
    7. China Cord Blood Corporation Continues Share Repurchase Program
    8. Journal of Renewable and Sustainable Energy highlights energy trends in China
    9. WuXi PharmaTech Named a Top Ten Outsourcing Enterprise in China for Five Consecutive Years
    10. Sinovac to Present at 55th Annual BioPharma China Convention 2012 - Vaccine & Antibody Focus
    11. China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2012
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/4/2015)... 4, 2015   ... Diagnostik und Therapie, Strahlendosismanagement und IT-Lösungen für die ... Royal Philips (NYSE: PHG, AEX: PHIA) gab ... (ECR) bekannt, der vom 4. bis 8. März in ... Ständen Nr. 102 and 110 wird ...
    (Date:3/3/2015)... 2015 NASA astronaut Scott Kelly , who ... spend a year living and working on the International Space ... to 7 a.m. EDT Monday, March 9. Kelly ... completes the final weeks of his training. The interviews will ... Television highlighting his mission training and previous spaceflights. ...
    (Date:3/3/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rcv4lq/gene_therapy ) has ... 2015 - 2025" report to their offering. ... an extensive study on the marketed and pipeline gene ... in this field for over a decade but there ... markets; one approved in the EU). There are many ...
    (Date:3/3/2015)... March 3, 2015 Adaptive Biotechnologies announced today ... joining its Board of Director as Chair of the ... Zillow Group, Chad oversees all finance, treasury and accounting ... company,s core finance, treasury and accounting functions, and led ... acquisitions. In 2013, he was named Puget Sound Business ...
    Breaking Biology Technology:Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 2Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 3Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 4Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 5Philips stellt integrierte Bildgebungslösungen auf dem Europäischen Röntgenkongress 2015 vor 6NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7Adaptive Biotechnologies adds Chad Cohen, Zillow Group CFO, to Board of Directors 2
    ... Northwestern University have nanoengineered a new kind of fiber ... a multidisciplinary team that includes groups from other universities ... Nancy J. Farley Professor in Manufacturing & Entrepreneurship at ... his group have created a high performance fiber from ...
    ... Inc. (Nasdaq: SQNM ) today announced that ... that priced on December 2, 2010 have exercised in ... of its common stock.  Including the additional shares being ... public offering price of $6.00 per share, resulting in ...
    ... have discovered a simple way to make carbon ... researcher Bruce Weisman, a pioneer in nanotube spectroscopy, ... batches of single-walled carbon nanotubes and exposing them ... atoms and systematically changes their near-infrared fluorescence. ...
    Cached Biology Technology:Researchers create new high-performance fiber 2Researchers create new high-performance fiber 3Sequenom Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Sequenom Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Light touch brightens nanotubes 2Light touch brightens nanotubes 3
    (Date:2/5/2015)... 2015  Marken is starting its 35 th ... a new marketing campaign to solidify its place as ... campaign focuses on First as a primary ... The first headline in the series, ... its client,s priorities. Marken recognizes the need to protect ...
    (Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
    (Date:2/5/2015)... SAN FRANCISCO , January 28, 2015 ... Camera Market Analysis, Size And Segment Forecasts To 2020 ... The global IR camera market is expected to reach ... study by Grand View Research, Inc. IR cameras help ... injuries, and are expected to witness surging demand in ...
    Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
    ... sham acupuncture treatments may help alleviate side effects of drugs ... CANCER , a peer-reviewed journal of the American Cancer ... patients. The results also raise the question of whether sham ... beneficial effects. Breast cancer patients who take a type ...
    ... 22, 2013Scientists at The Scripps Research Institute (TSRI) have ... the rapid selection of chemical compounds that have a ... compounds work. To illustrate the power of the ... a compound that shows promise for treating obesity-linked diabetes. ...
    ... A team of researchers studying plants has assembled the ... order in which flowering plants evolved specific strategies, such ... areas with cold winters. The researchers, including University of ... Dec. 22 in the journal Nature . ...
    Cached Biology News:Breast cancer patients experience fewer side effects from anticancer drug when receiving acupuncture 2Innovative screening strategy swiftly uncovers new drug candidates, new biology 2Innovative screening strategy swiftly uncovers new drug candidates, new biology 3Innovative screening strategy swiftly uncovers new drug candidates, new biology 4Researchers create largest evolutionary 'timetree' of land plants to investigate traits that permit survival in cold climates 2Researchers create largest evolutionary 'timetree' of land plants to investigate traits that permit survival in cold climates 3
    Acid phosphatase (Potato). Monospecific by IEP. Some cross reactivity between Acid phosphatases of other species may occur....
    Rat monoclonal [HK5.3] to B7 RP1 (Biotin) ( Abpromise for all tested applications). entrezGeneID: 23308 SwissProtID: O75144...
    ... Yersinia pestis This antibody is ... Immunogen: Purified F1 ... vaccine strain EV76. Specificity: ... capsular antigen. There is no cross-reactivity ...
    Phospho-SEK1/MKK4 (Thr261) Antibody...
    Biology Products: